{"version":"1.0","type":"rich","provider_name":"Everlit","provider_url":"https://everlit.audio/","title":"A Framingham biotech just became a $1.9B Italian acquisition. Here’s the drug behind it","description":"A Massachusetts pharma company just got absorbed by a European giant — and the drug at the center of it all treats a deadly disease.","author_name":"Advance Local","thumbnail_url":"https://cdn.everlit.audio/covers/artl_1Pn5bC47b8a/29bfc798-166d-495d-a893-29682a583608/small.jpg","width":480,"height":136,"html":"\u003ciframe title=\"A Framingham biotech just became a $1.9B Italian acquisition. Here’s the drug behind it\" src=\"https://everlit.audio/embeds/artl_1Pn5bC47b8a\" width=\"100%\" height=\"136px\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" allowfullscreen\u003e\u003c/iframe\u003e"}